Zoledronic acid – July 2023

• Brand name:
  • APO-Zoledronic Acid®
• Pharmaceutical Company:
  • Apotex Pty Ltd
• Condition/Indication: Breast cancer
• Meeting Date: July 2025
• Public Summary Document (PSD) December 2022 July 2023 PBAC Meetings - (PDF 512KB)
• Public Summary Document (PSD) December 2022 July 2023 PBAC Meetings - (Word 77KB)

Related Public Summary Documents

• Zoledronic acid – December 2022